Buyer profile
NHS England
Get alerts when NHS England publishes a new tender — 7-day free trial, then £4.99/month.
Total contracts
1,930
Known spend
£211bn
1801 disclosed
Average value
£117m
Per contract
Active suppliers
10
Last 5 years
Top suppliers
Last 5 years- 1
University College London Hospitals NHS Foundation Trust
19 winslatest 22 Sept 2026£5bn
- 2
ACCORD-UK LTD
£2bn
- 3
Zentiva Pharma UK Ltd
17 winslatest 27 Aug 2026£2bn
- 4
Teva UK Limited
15 winslatest 27 Aug 2026£2bn
- 5
Pfizer Ltd
14 winslatest 27 Aug 2026£3bn
- 6
Imperial College Healthcare NHS Trust
13 winslatest 28 Jan 2026£5bn
- 7
Guy's and St Thomas' NHS Foundation Trust
12 winslatest 22 Sept 2026£11bn
- 8
DR REDDY'S LABORATORIES (UK) LIMITED
£1bn
- 9
Cambridge University Hospitals NHS Foundation Trust
11 winslatest 18 May 2026£5bn
- 10
Sheffield Teaching Hospitals NHS Foundation Trust
11 winslatest 22 Sept 2026£775m
What they buy
By CPV categoryHealth & social workCPV 85
320 contracts · £42bn
Medical equipment & pharmaCPV 33
163 contracts · £25bn
Business servicesCPV 79
92 contracts · £270m
IT servicesCPV 72
58 contracts · £521m
Education & trainingCPV 80
41 contracts · £42m
SoftwareCPV 48
24 contracts · £1bn
R&D servicesCPV 73
21 contracts · £9m
Architectural & engineeringCPV 71
10 contracts · £334m
Renewal radar
Awarded contracts predicted to come up for re-tender in the next 18 months
- HSCN-AWS Connectivity Service for Spine
Predicted using median duration of UK contracts in the same CPV division (11 months from contract start date → renewal expected by May 2027).
May 2027
40% confident
- LeDeR Web Platform
Predicted using median duration of past contracts from this buyer in the same CPV division (11 months from contract start date → renewal expected by Jul 2027).
Jul 2027
60% confident
- Cyber School - Off The Shelf
Predicted using median duration of UK contracts in the same CPV division (15 months from contract start date → renewal expected by Nov 2027).
Nov 2027
40% confident
Tender activity
Notices published per month — last 24 months
All contracts (1930)
Growth and expansion of the individual placement and support programme
NHS England's plan to double access to IPS for people with severe and enduring mental illness by 20/21 presents the opportunity for a delivery partner to co-ordinate a response to
NHS national framework agreement for the supply of homecare delivery service - products for the treatment of bleeding disorders in england, wales and northern ireland
NHS National Framework agreement for the supply of Homecare Delivery Service - Products for the treatment of bleeding disorders in England, Wales and Northern Ireland. 1st July 201
Contract award notice for NHS rightcare recruitment support
The contract is for a specialist recruitment and executive selection agency for the proposed new National and Regional RightCare teams in NHS England with Axon Resourcing Ltd. The
Market engagement - patient participation in prison healthcare in the north of england
NHS England will work in partnership with patients and the public, to improve patient safety, patient experience and health outcomes; supporting people to live healthier lives. By
Responsible officer training
The Authority wishes to engage the services of a suitably qualified partner in order to provide proper support for implementation of the Medical Profession (Responsible Officers) R
Specialised - dose banding - london cancer network
Dose banding, London cancer network
Specialised - bleeding disorders
The products to be included in the procurement exercise are: Recombinant factor VIIa, PDFVIII containing vWF concentrate, PDFIX concentrate, PD pure vWF concentrate, PD Factor VIII
Specialised - icatibant and C1 esterase products for the treatment of hereditary angioedema
Hereditary Angioedema
NHS england website development
Contract Award for development services for the revision of the NHS England website, encompassing user need and customer requirements.
Specialised - factor X and porcine factor VIII
NHS National Framework Agreement for Factor X and Porcine Factor VIII Additional information: The product outlined in this future opportunity notice has been incorporated into the
Specialised - promthrombin complex concentrate (PCC)
Promthrombin Complex Concentrate (PCC) Additional information: The product outlined in this future opportunity notice has been incorporated into the OPEN current future opportunity
In practice development (clinical pharmacists)
This contract will provide in practice development for pharmacists ensuring the optimal solution for NHS England's internal clients' requirements. The key objective of the contract
Data analysis for cancer quality of life metric pilot
This requirement seeks appointment of an academic supplier to conduct data analysis and presentation as part of a pilot to develop the national quality of life metric for cancer. T
Data analysis for cancer quality of life metric pilot
NHS England is holding a market engagement session on 29th August 2017 at 1000hrs BST in order for interested parties to find out more about this project. Please confirm you attend
NHS pharmaceuticals 2017_2
NHS Pharmaceuticals 2017_2. Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months. Potential periods of call-offs under
NHS generic pharmaceuticals - clozapine
NHS National Framework Agreement for Generic Pharmaceuticals - Clozapine.
NHS framework agreement - national generic pharmaceuticals - clozapine
NHS Framework Agreement for the supply of Clozapine Initial contract Period of Framework - 01/04/2018 - 31/03/2020, with the provision to extend up to a period or Period (s) of 24
Hosting and support for NHS england websites
Web Hosting Services for NHS England
Health and social care provision for HMP liverpool
North of England Commissioning Support (NECS) is a commissioning support service hosted by NHS England and is managing this procurement process for and on behalf of NHS England Nor
Homecare delivery service - blood clotting factors
NHS National Framework agreement for the Homcare delivery service of licensed products for the use in England and Wales for the treatment of bleeding disorders including recombinan